Systems and methods for combined vertical/lateral flow blood separation technologies with enablement of point-of-care cotinine detection with extended range

US2016349252A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016349252-A1
Application numberUS-201615167533-A
CountryUS
Kind codeA1
Filing dateMay 27, 2016
Priority dateMay 29, 2015
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system for determining a level of cotinine in a sample includes a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a second lateral flow test strip, the first and second lateral flow test strips each having an overlapping but non-identical range for cotinine. The system further includes a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine.

First claim

Opening claim text (preview).

What is claimed as new and desired to be protected by Letters Patent of the United States is: 1 . A system for determining a level of cotinine in a sample, comprising: a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a second lateral flow test strip, the first and second lateral flow test strips each having an overlapping but non-identical range for cotinine; and a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine. 2 . The system of claim 1 , wherein the first and second lateral flow test strips each include microparticles combined with a cotinine antibody. 3 . The system of claim 2 , wherein the first and second lateral flow test strips each include compounds to bind with the microparticles combined with a cotinine antibody. 4 . The system of claim 3 , wherein for the first test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 3 . 5 . The system of claim 3 , wherein for the second test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 4 . 6 . The system of claim 4 , wherein for the second test strip the microparticles combined with a cotinine antibody include an antibody for cotinine 4 , and the combination of the first and second test strips results in a larger testing range for cotinine using the test strip system. 7 . The system of claim 6 , wherein the antibody for cotinine 3 is monoclonal. 8 . The system of claim 6 , wherein the antibody for cotinine 4 is polyclonal. 9 . The system of claim 6 , wherein the test strip system includes a red blood cell separation membrane. 10 . The system of claim 9 , wherein the red blood cell separation membrane is a vertical flow membrane. 11 . The system of claim 10 , wherein the test strip system includes a sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad, the red blood cell separation membrane, and the first and second lateral flow test strips. 12 . The system of claim 10 , wherein the test strip system includes a wicking membrane in a cartridge, and the cartridge holding the red blood cell separation membrane and the wicking membrane forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, and the wicking membrane oriented in contact with the first and second lateral flow test strips in order to provide sample to the lateral flow test strips. 13 . A system for determining a level of cotinine in a sample, comprising: a test strip system configured to receive a sample; and a meter configured to receive the test strip, wherein the meter is configured to read the test strip and detect a level of cotinine. 14 . The system of claim 13 , wherein the test strip system includes a red blood cell separation membrane. 15 . The system of claim 14 , wherein the test strip system includes a lateral flow test strip. 16 . The system of claim 15 , wherein the test strip system includes a red blood cell separation membrane. 17 . The system of claim 16 , wherein the red blood cell separation membrane is a vertical flow membrane. 18 . The system of claim 17 , wherein the test strip system includes a wicking membrane in the cartridge. 19 . The system of claim 18 , wherein a cartridge holds the red blood cell separation membrane and the wicking membrane and forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, the wicking membrane oriented in contact with the lateral flow test strip in order to provide sample to the lateral flow test strip. 20 . The system of claim 19 , wherein the lateral flow test strip includes microparticles combined with a cotinine antibody. 21 . The system of claim 20 , wherein the test strip includes a first test site, the first test site including compounds to bind with the microparticles combined with a cotinine antibody. 22 . The system of claim 21 , wherein the microparticles are fluorescent. 23 . The system of claim 21 , wherein the microparticles have reflective properties. 24 . The system of claim 21 , wherein the microparticles have properties that provide for the absorption of light. 25 . The system of claim 24 , wherein the meter measures a level of absorption at the first test site to determine the level of cotinine. 26 . The system of claim 23 , wherein the meter measures a level of reflection at the first test site to determine the level of cotinine. 27 . A method of determining a level of cotinine in a sample comprising: providing a test strip system configured to receive a sample wherein the test strip system includes microparticles combined with a cotinine antibody; providing a meter configured to receive the test strip wherein the meter is configured to read the test strip and detect a level of cotinine; placing a sample on the test strip; laterally flowing the sample of the test strip; and reading the test strip with the meter. 28 . The method of claim 27 , wherein the test strip system includes: a sample pad; and a cartridge, the sample pad oriented in line with an opening in a cartridge, the cartridge holding the sample pad, the red blood cell separation membrane, and the lateral flow test strip. 29 . The method of claim 28 , wherein the test strip system includes a wicking membrane in the cartridge. 30 . The method of claim 29 , wherein the cartridge holding the sample pad, the red blood cell separation membrane, and the wicking membrane forms a stack of membranes in that order, the stack of membranes being approximately in vertical alignment with the opening, the wicking membrane oriented in contact with the lateral flow test strip in order to provide sample to the lateral flow test strip. 31 . The method of claim 27 , further comprising binding at least a portion of cotinine with microparticles combined with the cotinine antibody; and binding at least a portion of the microparticles combined with the cotinine antibody to a first test site; wherein the reading of the test strip includes detecting at the first test site to determine the level of cotinine.

Assignees

Inventors

Classifications

  • CNS-stimulants, e.g. cocaine, amphetamines · CPC title

  • the carrier being characterised by its particulate form · CPC title

  • involving narcotics {or drugs or pharmaceuticals, neurotransmitters or associated receptors} · CPC title

  • involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)} · CPC title

  • Analytical elements · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016349252A1 cover?
A system for determining a level of cotinine in a sample includes a test strip system configured to receive a sample, the test strip system including a first lateral flow test strip and a second lateral flow test strip, the first and second lateral flow test strips each having an overlapping but non-identical range for cotinine. The system further includes a meter configured to receive the test…
Who is the assignee on this patent?
Polymer Technology Systems Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/54386. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).